Therefore, in-depth understanding of the molecular mechanism of BRD4 in PC can help to find the genes that may be regulated by BRD4, and the design of targeted inhibitors for both may be a new therapeutic direction. This evidence concerns the gene BRD4 and pachyonychia congenita.